| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |